Full metadata record
DC FieldValueLanguage
dc.creatorPerez, C. (Cristina)-
dc.creatorPascual, M. (Marien)-
dc.creatorMartin-Subero, J.I. (Jose Ignacio)-
dc.creatorBellosillo, B. (Beatriz)-
dc.creatorSegura, V. (Víctor)-
dc.creatorDelabesse, E. (Eric)-
dc.creatorAlvarez, S. (Sara)-
dc.creatorLarrayoz, M.J. (María J.)-
dc.creatorRifon, J. J. (Jose J.)-
dc.creatorCigudosa, J.C. (Juan Cruz)-
dc.creatorBesses, C. (Carles)-
dc.creatorCalasanz-Abinzano, M.J. (Maria Jose)-
dc.creatorCross, N.C.P. (Nicholas C.P.)-
dc.creatorProsper-Cardoso, F. (Felipe)-
dc.creatorAgirre-Ena, X. (Xabier)-
dc.date.accessioned2014-08-31T11:44:24Z-
dc.date.available2014-08-31T11:44:24Z-
dc.date.issued2013-09-
dc.identifier.citationPérez C, Pascual M, Martín-Subero JI, Bellosillo B, Segura V, Delabesse E, et al. Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms. Haematologica. 2013 Sep;98(9):1414-1420es_ES
dc.identifier.issn0390-6078-
dc.identifier.urihttps://hdl.handle.net/10171/36425-
dc.description.abstractMost DNA methylation studies in classic Philadelphia-negative myeloproliferative neoplasms have been performed on a gene-by-gene basis. Therefore, a more comprehensive methylation profiling is needed to study the implications of this epigenetic marker in myeloproliferative neoplasms. Here, we have analyzed 71 chronic (24 polycythemia vera, 23 essential thrombocythemia and 24 primary myelofibrosis) and 13 transformed myeloproliferative neoplasms using genome-wide DNA methylation arrays. The three types of chronic Philadelphia-negative myeloproliferative neoplasms showed a similar aberrant DNA methylation pattern when compared to control samples. Differentially methylated regions were enriched in a gene network centered on the NF-κB pathway, indicating that they may be involved in the pathogenesis of these diseases. In the case of transformed myeloproliferative neoplasms, we detected an increased number of differentially methylated regions with respect to chronic myeloproliferative neoplasms. Interestingly, these genes were enriched in a list of differentially methylated regions in primary acute myeloid leukemia and in a gene network centered around the IFN pathway. Our results suggest that alterations in the DNA methylation landscape play an important role in the pathogenesis and leukemic transformation of myeloproliferative neoplasms. The therapeutic modulation of epigenetically-deregulated pathways may allow us to design targeted therapies for these patients.es_ES
dc.language.isoenges_ES
dc.publisherFerrata Storti Foundationes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectMyeloproliferative disorderses_ES
dc.subjectPolycythemia veraes_ES
dc.subjectChronic diseasees_ES
dc.subjectDNA methylationes_ES
dc.subjectHumanses_ES
dc.titleAberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttp://dx.doi.org/10.3324/haematol.2013.084160es_ES

Files in This Item:
Thumbnail
File
0981414.pdf
Description
Size
611.85 kB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.